Literature DB >> 2481178

The effect of beta-blockade on platelet function and fibrinolytic activity.

K Winther1.   

Abstract

Two groups of hypertensives and a group of migraine sufferers were tested during treatment with the nonselective beta-blocker propranolol and the beta 1-selective metoprolol. During treatment with propranolol, an increased platelet aggregability and a decrease in platelet content of cyclic AMP were seen when compared with metoprolol treatment. In addition, propranolol treatment increased the plasma level of adrenaline as well as the euglobulin clot lysis time.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2481178

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.

Authors:  Bahman Tarighi; Turhan Kurum; Muzaffer Demir; Sen Nur Azcan
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

2.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.

Authors:  H Sengeløv; K Winther
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.

Authors:  G Ranieri; V Filitti; A Andriani; M V Bonfantino; G Lamontanara; A Cavallo; M Milani; R De Cesaris
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

Review 5.  A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.

Authors:  M J Kendall; I Rajman
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

6.  Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer.

Authors:  Maria Dobre; Alessandro Salvi; Iulia Andreea Pelisenco; Florina Vasilescu; Giuseppina De Petro; Vlad Herlea; Elena Milanesi
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.